BioCardia (BCDA)
Develops cell therapies and catheter systems for heart and lung diseases.
$1.09
After hours+0.04 (+3.32%)
At close$1.06(−2.31%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 8.81% | 1.33M shares | |
|---|---|---|---|
| 21 holders · as of Jun 30, 2026 | |||
| Insiders | 13.49% | 2.04M shares | |
| 8 holders · as of Sep 4, 2026 | |||
| Other | 77.70% | 11.76M shares | |
| remainder | |||
15.14M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
21 holders · 1.33M shares · 8 new positions · 12 increased · 3 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Citigroup Inc | 397.6K | 2.63% | +397.6Knew | Aug 3, 2026 |
| CM Management, LLC | 300.0K | 1.98% | +170.0K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 124.6K | 0.82% | 0 | Aug 13, 2026 |
| Pingora Partners LLC | 120.4K | 0.80% | +84.6K | Aug 14, 2026 |
| UBS Group AG | 77.6K | 0.51% | +77.6K | Aug 13, 2026 |
| Geode Capital Management, LLC | 66.7K | 0.44% | −27.6K | Aug 12, 2026 |
| Vanguard Fiduciary Trust Co | 66.3K | 0.44% | 0 | Aug 13, 2026 |
| Susquehanna International Group, LLP | 38.8K | 0.26% | −18 | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Thomas A. Satterfield, Jr. | 9.90% | 592.1K | 13G | Aug 13, 2025 |
| Lincoln Alternative Strategies LLC | 7.54% | 800.0K | 13G | Sep 19, 2025 |
| Blank Andrew Scott | 5.50% | 278.3K | 13D | May 22, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 3, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 800 | $1.09 | 381,985 |
| Aug 17, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 5,400 | $0.9300 | 381,115 |
| Aug 13, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 1,900 | $0.9200 | 375,785 |
| Jul 29, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 5,000 | $0.7800 | 373,885 |
| Jul 17, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 500 | $0.8300 | 368,885 |
| Jul 14, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 2,800 | $0.8800 | 366,885 |
| Jul 15, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 1,500 | $0.8600 | 368,385 |
| Jul 8, 2026 | Peter Altmandirector, officer: President and CEO | Purchase · 2 lots | 10,900 | $0.9673 | 367,485 |
| Jul 9, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 1,000 | $0.9000 | 368,485 |
| Jul 10, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 1,000 | $0.9400 | 369,485 |
House and Senate disclosures
Not reported.